Stay updated on pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Sign up to get notified when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.

Latest updates to the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page
- Check3 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the Back to Top element; no changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated to include information on Melanoma under MedlinePlus Genetics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has added a facility name and location related to skin and connective tissue diseases, while also removing several specific disease-related resources and terms, including references to pembrolizumab and various genetic diseases.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to pIL-12/MK-3475 Combo for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pIL-12/MK-3475 Combo for Melanoma Clinical Trial page.